Clinical significance of different antinuclear antibodies patterns in the course of primary biliary cirrhosis

Hepato-Gastroenterology

Volumn 43, Issue 11, 1996, Pages 1135-1140

  Remmel, Triin ^a   Piirsoo, Andres ^a   Koiveer, Anu ^a   Remmel, Hele ^a   Uibo, Raivo ^a   Salupere, Vello ^a  

^a UNIVERSITY OF TARTU   (Estonia)

Author keywords

Antinuclear antibodies; Liver cirrhosis; Liver disease; Primary biliary cirrhosis; Prognosis

Indexed keywords

ANTINUCLEAR ANTIBODY; AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ALCOHOL LIVER DISEASE; ARTICLE; AUTOIMMUNE HEPATITIS; CELL LINE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; HEP 2 CELL; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; SYMPTOM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANALYSIS OF VARIANCE; ANIMALS; ANTIBODIES, ANTINUCLEAR; AUTOIMMUNE DISEASES; CELL LINE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; LIVER CIRRHOSIS, BILIARY; LIVER DISEASES; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0029973551     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Kaplan MM. Primary biliary cirrhosis. N J Med 1987; 316: 521-528.
2. Sherlock S, Scheuer PJ. The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med 1973; 289:674-678.
3. James O, Macklon AF, Watson AJ. Primary biliary cirrhosis: a revised clinical spectrum. Lancet 1981; ii:1278-1281.
4. Bassendine MF, Yeaman SJ. Serological markers of primary biliary cirrhosis: diagnosis, prognosis and subsets. Hepatology 1992;15:545-548.
5. Bernstein RM, Neuberger JM, Bunn CC, Callender ME, Hughes GRV, Williams R. Diversity of autoantibodies in primary biliary cirrhosis and chronic active hepatitis. Clin Exp Immunol 1984; 55:553-560.
6. Powell F, Schroeter AL, Dickson ER. Antinuclear antibodies in primary biliary cirrhosis. Lancet 1984; 1:288-289.
7. Cassani F, Bianchi FB, Lenzi M, Volta U, Pisi E. Immunomorphological characterisation of antinuclear antibodies in chronic liver disease. J Clin Pathol 1985; 38:801-805.
8. Lassoued K, Brenard R, Degos F, et al. Antinuclear antibodies directed to 200 kD polypeptide of the nuclear envelope in primary biliary cirrhosis. A clinical and immunological study of a series of 150 patient with primary biliary cirrhosis. Gastroenterology 1990; 90:181-186.
9. Hansen BU, Eriksson S, Lindgren S. High prevalence of autoimmune liver disease in patients with multiple nuclear dot, anti-centromere and mitotic spindle antibodies. Scand J Gastroenterol 1991; 26:707-713.
10. Lassoued K, Guilly MN, Andre C, et al. Autoantibodies to 200 kD polypeptide(s) of the nuclear envelope: a new serological marker of primary biliary cirrhosis. Clin Exp Immunol 1988;74:283-288.
11. Nickowitz RE, Wozniak RW, Schaffner F, Worman HJ. Autoantibodies against integral membrane proteins of the nuclear envelope in patients with PBC. Gastroenterology 1994;106:193-199.
12. Scheuer PJ. Liver biopsy interpretation. London: Bailliere Tindall, 1988.
13. Walker JG, Doniach D, Roitt IM, Sherlock S. Serological tests in the diagnosis of primary biliary cirrhosis. Lancet 1965;i:827-831.
14. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations J Amer Stat Assoc 1958; 53:457-481.
15. Taylor SL, Dean PJ, Riely CA. Primary autoimmune cholangitis. An alternative to antimitochondrial antibody-negative primary biliary cirrhosis. Am J Surg Pathol 1994;18:91-99.
16. Michiletti P, Wanless IR, Katz A, Scheuer PJ, Yeaman SJ, Bassendine MF, Palmer JM, Heathcote EJ. Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis. Gut 1994;35:26-265.
17. Goodman ZD, MsNally PR, Davos DR, Ishak KG. Autoimmune cholangitis: a variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases. Dig Dis Sci 1995; 40:1232-1242.
18. Lacerda MA, Ludwig J, Dickson ER, Jorgensen RA, Lindor KD. Antimitochondrial antibody- negative primary biliary cirrhosis. Am J Gastroenterol 1995; 90:247-249.
19. Szostecki C, Krippner H, Penner E, Bautz FA. Autoimmune sera recognize a 100 kD nuclear protein antigen (sp-100). Clin Exp Immunol 1987;68:108-116.
20. Pawlotsky J-M, Andre C, Metreau J-M, Beaugrand M, Zafrani E-S, Dhumeaux D. Multiple nuclear dots antinuclear antibodies are not specific for primary biliary cirrhosis. Hepatology 1992;16:127-131.
21. Szostecki C, Guldner HH, Netter HJ, Will H. Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. J of Immunology 1990;145:4338-4347.
22. Szostetcki C, Will H, Netter HJ, Guldner HH. Autoantibodies to nuclear Sp100 protein in primary biliary cirrhosis and associated diseases: epitope specifity and immunoglobulin class distribution. Scand J Immunol 1992; 36:555-564.
23. Roll J, Boyer JL, Barry D, Klatskin G. The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis. N Engl J Med 1983; 308:1-7.
24. Jeffrey GP, Reed WD, Shilkin KD. Primary biliary cirrhosis: clinicopathological characteristics and outcome. J Gastroenterol Hepatol 1990; 5:639-645.
25. Rydning A, Schrumpf E, Adbelnoor M, Elgjo K, Jenssen E. Factors of prognostic importance in primary biliary cirrhosis. Scand J Gastroenterol 1990; 25:119-126.
26. Mitchison HC, Lucey MR, Kelly PJ, Neuberger JM, Williams R, James OF. Symptom development and prognosis in primary biliary cirrhosis: a study in two centres. Gastroenterology 1990; 99:778-784.
27. Wiesner RH, Porayko HK, Dickson ER, et al. Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 1991; 16:1290-1299.
28. Imai H, Nakano Y, Kiyosawa K, Tan EM. Increasing titers and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma. Cancer 1993; 71:26-35.